DRUG/DEVICE

Autologous endothelial progenitor cells transfected with human endothelial nitric oxide synthase, for intravenous use

ROUTE OF ADMINISTRATION

Intravenous

THERAPEUTIC PLATFORM

NCE / Novel Biologics

CLINICAL TRIAL

TERRITORY

Canadian Study; United States license

STATUS

Registration phase study in Canada

Aurora-GT™ is a development-stage product not approved for sale in any jurisdiction.